ALENDRONATE SODIUM powder

Ülke: ABD

Dil: İngilizce

Kaynak: NLM (National Library of Medicine)

şimdi satın al

Indir Ürün özellikleri (SPC)
09-11-2022

Aktif bileşen:

ALENDRONATE SODIUM (UNII: 2UY4M2U3RA) (ALENDRONIC ACID - UNII:X1J18R4W8P)

Mevcut itibaren:

AX Pharmaceutical Corp

Uygulama yolu:

NOT APPLICABLE

Reçete türü:

BULK INGREDIENT -

Yetkilendirme durumu:

Bulk Ingredient For Animal Drug Compounding

Ürün özellikleri

                                ALENDRONATE SODIUM- ALENDRONATE SODIUM POWDER
AX PHARMACEUTICAL CORP
----------
ALENDRONATE SODIUM
ALENDRONATE SODIUM
ALENDRONATE SODIUM
alendronate sodium powder
PRODUCT INFORMATION
PRODUCT TYPE
ITEM CODE (SOURCE)
NDC:73377-173
ROUTE OF ADMINISTRATION
NOT APPLICABLE
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH STRENGTH
ALENDRONATE SODIUM (UNII: 2UY4M2U3RA) (ALENDRONIC ACID -
UNII:X1J18R4W8P)
ALENDRONATE
SODIUM
1 g in 1 g
PRODUCT CHARACTERISTICS
COLOR
white
SCORE
SHAPE
SIZE
FLAVOR
IMPRINT CODE
CONTAINS
PACKAGING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1 NDC:73377-173-01
100 g in 1 JAR
AX Pharmaceutical Corp
MARKETING INFORMATION
MARKETING CATEGORY
APPLICATION NUMBER OR
MONOGRAPH CITATION
MARKETING START
DATE
MARKETING END
DATE
bulk ingredient for animal drug
compounding
11/09/2022
LABELER -
AX Pharmaceutical Corp (204011316)
ESTABLISHMENT
NAME
ADDRESS
ID/FEI
BUSINESS OPERATIONS
AX Pharmaceutical Corp
204011316
relabel, repack
ESTABLISHMENT
NAME
ADDRESS
ID/FEI
BUSINESS OPERATIONS
Cadila Pharmaceuticals Limited
916130698
api manufacture
Revised: 11/2022
                                
                                Belgenin tamamını okuyun
                                
                            

Bu ürünle ilgili arama uyarıları

Belge geçmişini görüntüleyin